Ozempic is for patients managing their type 2 diabetes, while Wegovy is specifically for chronic weight management in adults with obesity or those who are overweight with related health issues
Novo Nordisk ha solicitado al regulador farmacutico chino la ampliacin del mbito de uso de la semaglutida, segn la Administracin Nacional de Productos Mdicos
When McLaughlin told her nurse practitioner about her disordered eating history, she was told she would have to stop taking the medication
Patients get personalized care, education, and ongoing follow-ups to ensure they feel comfortable and see great results with Ozempic therapy
The GLORY-1 trial reported gastrointestinal symptoms as the most common adverse events, but discontinuation rates due to these effects remained low
A 150-pound person and a 350-pound person follow the same dose escalation steps